Accretive Health (ACHI) 7.3000 $ACHI
Decision Diagnostics Corp. Addresses FDA Safety Warning Letter
ACCESSWIRE - Thu May 01, 8:36AM CDT
Decision Diagnostics Corp.'s (OTCQB: DECN) stock volume soared, with 1,755,856 changing hands, 11 times more than its three-month average volume of 149,093 shares.
Steve Schuckenbrock to Step Down as Accretive Health President & CEO
Business Wire - Wed Apr 23, 3:01PM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has accepted the resignation of Steve Schuckenbrock as president and CEO, effective October 2, 2014, which is the completion of his contract term. The Board of Directors has initiated a search for a new CEO with deep healthcare domain expertise to lead the company through its next phase of operational enhancement, as well as reigniting the company's growth and strategic innovation. Schuckenbrock will continue to serve on Accretive Health's Board of Directors, remain as President and CEO through his contract term, enabling a stable transition to a new CEO, and managing the completion of the company's financial restatement as soon as possible.
Accretive Health Names Steve Shulman as Chairman of the Board
Business Wire - Fri Apr 04, 6:30AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that Steve Shulman, an independent member of the Company's Board of Directors since April 2013, has been elected Chairman of the Board of Directors effective April 2, 2014. This follows Mary Tolan's previously announced decision to step down as Chairman of the Board. Ms. Tolan will continue to serve as a director of the Company through Accretive Health's 2014 annual meeting of shareholders.
Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts
M2 - Tue Apr 01, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hnnrlm/healthcare_bpo) has announced the addition of the "Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts" report to their offering. The global healthcare BPO market is dominated by the U.S. A very large percentage of the healthcare BPO requirement arises out of the U.S. Europe is quickly emerging as another important source segment in this market. The U.S. and India are the two largest destination geographies. Philippines and Eastern Europe are two of the fastest growing destination segments in this market. The payer market is segmented into claims processing, member services, HR services, and finance and accounts segments. Claims processing is an important service segment in the payer outsourcing market. It is further sub-divided into claims indexing, claims investigation, claims adjudication, claims repricing, claims settlement, litigation management, and information management. The provider market is segmented into medical billing, medical coding, medical transcription, and finance and account segments. The pharmaceutical outsourcing market is segmented into contract research organizations (CRO), contract manufacturing organizations (CMO), and business support services. Each service segment in the pharmaceutical outsourcing market is divided into further sub-segments. The CRO service segment is sub-divided into drug discovery, pre-clinical, clinical phases I, II, III and IV, clinical data management and biostatistics, medical writing, regulatory services, and non-clinical functions. The CMO service segment is sub-divided into API manufacturing, and formulation and packaging. The non-clinical service segment is sub-divided into supply chain management and logistics, sales and marketing, and non-clinical functions. The report also highlights the marketing KPO function in the sales and marketing outsourcing segment. Scope Healthcare BPO Market Payer - Claims Processing - HR Services - Finance & Accounts Provider - Medical Billing & Coding Pharmaceutical - Clinical Trial - Contract Manufacturing - Non-Clinical Services Key Topics Covered: - Introduction - Executive Summary - Market Overview - Healthcare Payer Outsourcing Market - Healthcare Provider Outsourcing Market - Pharmaceutical Outsourcing Market - Geographical Analysis - Competitive Landscape - Company Profiles - Accenture Plc - Accretive Health, Inc. - Anthelio Healthcare Solutions, Inc. - Boehringer Ingelheim Gmbh - Catalent Pharma Solutions, Inc. - Charles River Laboratories International, Inc. - Cognizant Technology Solutions Corporation - Covance, Inc. - Gebbs Healthcare Solutions, Inc. - Genpact Limited - Ibm Corporation - Icon Plc - Igate Patni - Infosys Bpo Limited - Inventiv Health Inc - Lonza Group Ltd. - Medusind Solutions Inc - Mphasis Limited - Omega Healthcare Management Services Pvt Ltd - Parexel International Corporation - Patheon Inc - Pharmaceutical Product Development, Inc. - Piramal Enterprises Limited - Quintiles Transnational Holdings, Inc. - Tata Consultancy Services Ltd - Tech Mahindra - Teleradiology Solutions Pvt Ltd. - Wns (Holdings) Limited - Xerox Corporation Visit http://www.researchandmarkets.com/research/hn...thcare_bpo
Decision Diagnostics Corp. Addresses FDA Safety Warning Letter
ACCESSWIRE - Thu May 01, 8:36AM CDT
Decision Diagnostics Corp.'s (OTCQB: DECN) stock volume soared, with 1,755,856 changing hands, 11 times more than its three-month average volume of 149,093 shares.
Steve Schuckenbrock to Step Down as Accretive Health President & CEO
Business Wire - Wed Apr 23, 3:01PM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has accepted the resignation of Steve Schuckenbrock as president and CEO, effective October 2, 2014, which is the completion of his contract term. The Board of Directors has initiated a search for a new CEO with deep healthcare domain expertise to lead the company through its next phase of operational enhancement, as well as reigniting the company's growth and strategic innovation. Schuckenbrock will continue to serve on Accretive Health's Board of Directors, remain as President and CEO through his contract term, enabling a stable transition to a new CEO, and managing the completion of the company's financial restatement as soon as possible.
Accretive Health Names Steve Shulman as Chairman of the Board
Business Wire - Fri Apr 04, 6:30AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that Steve Shulman, an independent member of the Company's Board of Directors since April 2013, has been elected Chairman of the Board of Directors effective April 2, 2014. This follows Mary Tolan's previously announced decision to step down as Chairman of the Board. Ms. Tolan will continue to serve as a director of the Company through Accretive Health's 2014 annual meeting of shareholders.
Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts
M2 - Tue Apr 01, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hnnrlm/healthcare_bpo) has announced the addition of the "Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts" report to their offering. The global healthcare BPO market is dominated by the U.S. A very large percentage of the healthcare BPO requirement arises out of the U.S. Europe is quickly emerging as another important source segment in this market. The U.S. and India are the two largest destination geographies. Philippines and Eastern Europe are two of the fastest growing destination segments in this market. The payer market is segmented into claims processing, member services, HR services, and finance and accounts segments. Claims processing is an important service segment in the payer outsourcing market. It is further sub-divided into claims indexing, claims investigation, claims adjudication, claims repricing, claims settlement, litigation management, and information management. The provider market is segmented into medical billing, medical coding, medical transcription, and finance and account segments. The pharmaceutical outsourcing market is segmented into contract research organizations (CRO), contract manufacturing organizations (CMO), and business support services. Each service segment in the pharmaceutical outsourcing market is divided into further sub-segments. The CRO service segment is sub-divided into drug discovery, pre-clinical, clinical phases I, II, III and IV, clinical data management and biostatistics, medical writing, regulatory services, and non-clinical functions. The CMO service segment is sub-divided into API manufacturing, and formulation and packaging. The non-clinical service segment is sub-divided into supply chain management and logistics, sales and marketing, and non-clinical functions. The report also highlights the marketing KPO function in the sales and marketing outsourcing segment. Scope Healthcare BPO Market Payer - Claims Processing - HR Services - Finance & Accounts Provider - Medical Billing & Coding Pharmaceutical - Clinical Trial - Contract Manufacturing - Non-Clinical Services Key Topics Covered: - Introduction - Executive Summary - Market Overview - Healthcare Payer Outsourcing Market - Healthcare Provider Outsourcing Market - Pharmaceutical Outsourcing Market - Geographical Analysis - Competitive Landscape - Company Profiles - Accenture Plc - Accretive Health, Inc. - Anthelio Healthcare Solutions, Inc. - Boehringer Ingelheim Gmbh - Catalent Pharma Solutions, Inc. - Charles River Laboratories International, Inc. - Cognizant Technology Solutions Corporation - Covance, Inc. - Gebbs Healthcare Solutions, Inc. - Genpact Limited - Ibm Corporation - Icon Plc - Igate Patni - Infosys Bpo Limited - Inventiv Health Inc - Lonza Group Ltd. - Medusind Solutions Inc - Mphasis Limited - Omega Healthcare Management Services Pvt Ltd - Parexel International Corporation - Patheon Inc - Pharmaceutical Product Development, Inc. - Piramal Enterprises Limited - Quintiles Transnational Holdings, Inc. - Tata Consultancy Services Ltd - Tech Mahindra - Teleradiology Solutions Pvt Ltd. - Wns (Holdings) Limited - Xerox Corporation Visit http://www.researchandmarkets.com/research/hn...thcare_bpo
